Previous Blogs

Avatar

By Victoria Morgan

August 14, 2020

In the biologics space, there are clear trends toward higher delivery volumes, less frequent dosing, and the conversion from intravenous to subcutaneous delivery. This is driving demand for wearable technologies. Read more below about the FDA’s Patient-Focused Drug Development (PFDD) Initiative and how these findings can enable more insightful patient offerings.

Avatar

By Global Communications

July 03, 2014

Westpharma.com has been upgraded!  The new, mobile-friendly site offers easier navigation, intuitive design and  enhanced searchability. The new site is mobile-friendly, and can be easily viewed and navigated from phones and tablets.

Avatar

By Dr. Nicolas Brandes

March 03, 2014

Polymeric container systems are not new to the pharmaceutical industry, and their benefits in terms of break resistance, cosmetic quality and dimensional precision have been recognized by many companies around the world who have chosen to use a polymer vial or syringe.

Avatar

By Global Communications

November 08, 2013

West has completed a preliminary study of its SmartDose® technology platform, which incorporates a Daikyo Crystal Zenith® (CZ) cartridge. The study evaluated multiple attributes of the technology and subjects’ experience with the self-application process.

Avatar

By Graham Reynolds

October 14, 2013

West works by the side of our health care partners to understand patient needs and provide integrated delivery systems that optimize the effectiveness of drug delivery while enhancing the patient experience. Creative business models will ensure effective collaboration, either by leveraging West’s proprietary technologies or partnering with individual customers through the development process to apply West’s design, engineering and manufacturing skills to create customer-specific solutions.

Avatar

By Graham Reynolds

January 18, 2012

West’s Graham Reynolds will present “An Integrated Approach to Biologic Drug Delivery Systems: Meeting the needs of the patient, and optimizing drug product performance,” at the Drug Delivery Partnerships meeting in Las Vegas, on January 25, 2012.